Idiopathic uveal effusion syndrome

What it is

From: Orphanet

A rare panuveitis characterized by uni- or bilateral abnormal fluid accumulation within the suprachoroidal space, resulting in internal choroidal elevation, in the absence of any known cause, such as decreased intraocular tension, intraocular tumor, intraocular inflammation or nanophtalmos. Patients typically present a protracted, relapsing-remitting course of visual acuity loss and fundus examination shows annular celio-choroidal detachment and shifting, serous retinal detachment.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal sclera morphology · Very frequent (99-80%)

An abnormality of the sclera.

Abnormal anterior eye segment morphology · Frequent (79-30%)

An abnormality of the anterior segment of the eyeball (which comprises the structures in front of the vitreous humor: the cornea, iris, ciliary body, and lens).

Exudative retinal detachment · Frequent (79-30%)

A type of retinal detachment such that fluid is present in the subretinal space and separate the neurosensory retina from the retinal pigment epithelium. It is not associated with a full-thickness break nor a tractional component. Due to breakdown of outer blood-retina barrier or increased exudation from abnormal vasculature or defective outflow.

Increased CSF protein concentration · Frequent (79-30%)

Increased concentration of protein in the cerebrospinal fluid.

Scleral thickening · Frequent (79-30%)

Increased dimension of the sclera in the anterior-posterior axis.

Subretinal fluid · Frequent (79-30%)

Fluid accumulating between the neuroretina and retinal pigment epithelium.

Superficial episcleral hyperemia · Frequent (79-30%)

Prominence of blood vessels of the superficial episcleral tissues.

Reduced visual acuity · Frequent (79-30%)

Blurred vision · Occasional (29-5%)

Lack of sharpness of vision resulting in the inability to see fine detail.

Metamorphopsia · Occasional (29-5%)

A visual anomaly in which images appear distorted. A grid of straight lines appears wavy and parts of the grid may appear blank.

Microphthalmia · Occasional (29-5%)

A developmental anomaly characterized by abnormal smallness of one or both eyes.

Retinal fold · Occasional (29-5%)

A wrinkle of retinal tissue projecting outward from the surface of the retina and visible as a line on fundoscopy.

Visual field defect · Occasional (29-5%)

When it may begin

From: Orphanet

Adult

Inheritance in the source

From: Orphanet

Unknown

Which doctor should you see?

The suggested department for discussing Idiopathic uveal effusion syndrome is Ophthalmology, with a ophthalmologist as the relevant type of clinician. Ophthalmologist; paediatric services for children as appropriate.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Which part of the eye or visual pathway is affected?
• What change in vision requires immediate contact with the eye service?
• What are the aims and alternatives of any proposed eye treatment?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Idiopathic uveal effusion syndrome. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.